Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MBRX Moleculin Biotech, Inc.

盘后交易 01-14 18:56:33 EST

4.14

-0.15

-3.50%

盘后4.22

+0.08+1.93%

18:01 EST

最高4.45	最低4.06	成交量10.43万
今开4.45	昨收4.29	日振幅9.09%
总市值1,275万	流通市值1,256万	总股本307.92万
成交额43.42万	换手率3.44%	流通股本303.49万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech, Inc.","latestPrice":4.14,"timestamp":1768424400000,"preClose":4.29,"halted":0,"volume":104300,"hourTrading":{"tag":"盘后","latestPrice":4.22,"preClose":4.14,"latestTime":"18:01 EST","volume":1666,"amount":7152.395730199999,"timestamp":1768431675728},"delay":0,"floatShares":3034900,"shares":3079200,"eps":-78.860825,"marketStatus":"盘后交易","change":-0.15,"latestTime":"01-14 18:56:33 EST","open":4.45,"high":4.45,"low":4.06,"amount":434153.06802,"amplitude":0.090909,"askPrice":4.44,"askSize":2,"bidPrice":4.1,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-78.860825,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768438800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.29,"preHourTrading":{"tag":"盘前","latestPrice":4.45,"preClose":4.29,"latestTime":"09:28 EST","volume":1045,"amount":4458.717175,"timestamp":1768400891085},"postHourTrading":{"tag":"盘后","latestPrice":4.22,"preClose":4.14,"latestTime":"18:01 EST","volume":1666,"amount":7152.395730199999,"timestamp":1768431675728},"volumeRatio":0.634046},"requestUrl":"/m/hq/s/MBRX","defaultTab":"news","newsList":[{"id":"2603654532","title":"Moleculin Biotech, Inc.盘中异动 股价大涨5.06%报4.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603654532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603654532?lang=zh_cn&edition=full","pubTime":"2026-01-14 01:20","pubTimestamp":1768324805,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日01时20分，Moleculin Biotech, Inc.股票出现波动，股价快速拉升5.06%。截至发稿，该股报4.26美元/股，成交量9.1552万股，换手率2.97%，振幅8.40%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114012005a4bfbbc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114012005a4bfbbc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"1109614760","title":"Moleculin Biotech加速布局至2026年：首项关键试验揭盲如期推进，全球试验版图扩张，多项外部/IIT资助临床项目并行","url":"https://stock-news.laohu8.com/highlight/detail?id=1109614760","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109614760?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:36","pubTimestamp":1768224974,"startTime":"0","endTime":"0","summary":"Moleculin Biotech正将其战略视野加速延伸至2026年。公司首项关键临床试验的揭盲工作正按计划稳步推进，同时积极拓展全球试验网络。此外，多个由外部资金及研究者发起试验（IIT）资助的临床开发项目亦在同步开展，共同构筑起公司多元化的研发管线。这一系列动态标志着其在肿瘤治疗领域的深度布局进入新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"1111584864","title":"Moleculin公布WP1066针对儿童复发性恶性脑瘤治疗的I期临床试验积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1111584864","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111584864?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:33","pubTimestamp":1765978395,"startTime":"0","endTime":"0","summary":"Moleculin公布WP1066针对儿童复发性恶性脑瘤治疗的I期临床试验积极结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"1189715386","title":"Moleculin宣布完成45名患者在关键“奇迹”第三阶段AML试验中的治疗，预计于2026年第一季度汇报进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1189715386","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189715386?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:07","pubTimestamp":1765285649,"startTime":"0","endTime":"0","summary":"Moleculin宣布完成45名患者在关键“奇迹”第三阶段AML试验中的治疗，预计于2026年第一季度汇报进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2585174396","title":"Moleculin Biotech, Inc.盘中异动 股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585174396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585174396?lang=zh_cn&edition=full","pubTime":"2025-11-22 01:06","pubTimestamp":1763744807,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日01时06分，Moleculin Biotech, Inc.股票出现异动，股价大幅上涨5.55%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Osr Holdings, Inc.、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd.较为活跃，换手率分别为441.14%、20.33%、20.27%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Osr Holdings, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为63.22%、49.71%、47.00%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112201064897780d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112201064897780d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"1132644092","title":"Moleculin宣布资助研究，评估Annamycin在北卡罗来纳大学教堂山分校治疗胰腺癌的效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1132644092","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132644092?lang=zh_cn&edition=full","pubTime":"2025-11-12 21:38","pubTimestamp":1762954695,"startTime":"0","endTime":"0","summary":"Moleculin宣布资助研究，评估Annamycin在北卡罗来纳大学教堂山分校治疗胰腺癌的效果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"1121782358","title":"Moleculin将在第14届急性白血病年会上重点介绍其正在进行的第3期急性髓性白血病“奇迹”临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1121782358","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121782358?lang=zh_cn&edition=full","pubTime":"2025-10-30 20:42","pubTimestamp":1761828141,"startTime":"0","endTime":"0","summary":"Moleculin将在第14届急性白血病年会上重点介绍其正在进行的第3期急性髓性白血病“奇迹”临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2574107383","title":"Moleculin Biotech, Inc.盘中异动 早盘急速下挫5.06%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574107383?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:00","pubTimestamp":1760108409,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时00分，Moleculin Biotech, Inc.股票出现波动，股价急速跳水5.06%。截至发稿，该股报0.490美元/股，成交量50.3725万股，换手率1.02%，振幅5.00%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023000994c209f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023000994c209f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2572631598","title":"Moleculin Biotech, Inc.盘中异动 快速下挫6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572631598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572631598?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:43","pubTimestamp":1759499020,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时43分，Moleculin Biotech, Inc.股票出现波动，股价快速下跌6.34%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Alto Neuroscience, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Ovid Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Ovid Therapeutics Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为48.87%、46.04%、32.87%，振幅较大的相关个股有Alto Neuroscience, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Neurogene Inc.，振幅分别为32.88%、23.50%、17.59%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003214340971e79f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003214340971e79f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"1187912025","title":"Moleculin Biotech向SEC提交转售招股说明书 售股股东可不时出售至多6490万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1187912025","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187912025?lang=zh_cn&edition=full","pubTime":"2025-09-20 05:17","pubTimestamp":1758316634,"startTime":"0","endTime":"0","summary":"Moleculin Biotech向美国证券交易委员会(SEC)提交了转售招股说明书，允许售股股东不时出售至多6490万股普通股。这一申报文件已正式提交至SEC。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2566364204","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大涨5.14%报0.409美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566364204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566364204?lang=zh_cn&edition=full","pubTime":"2025-09-09 22:00","pubTimestamp":1757426431,"startTime":"0","endTime":"0","summary":"北京时间2025年09月09日22时00分，Moleculin Biotech, Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报0.409美元/股，成交量160.999万股，换手率5.32%，振幅4.24%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909220031978357f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250909220031978357f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"1179147367","title":"Moleculin Biotech, Inc.在欧盟启动治疗急性髓系白血病的3期关键性Miracle试验，首位患者已给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1179147367","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179147367?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:30","pubTimestamp":1757334625,"startTime":"0","endTime":"0","summary":"Moleculin Biotech, Inc.宣布在欧盟地区为其治疗急性髓系白血病的3期关键性Miracle试验首位患者进行给药治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2565531353","title":"Moleculin Biotech, Inc.盘中异动 大幅下挫6.05%报0.353美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565531353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565531353?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:52","pubTimestamp":1756993928,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日21时52分，Moleculin Biotech, Inc.股票出现波动，股价快速跳水6.05%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，冠科美博、Lexaria Bioscience Corp C/Wts 14/01/2026 、内克塔治疗涨幅较大，Purple Biotech Ltd、Soligenix, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1424.88%、128.15%、28.57%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Ernexa Therapeutics Inc.，振幅分别为35.56%、17.54%、17.33%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904215208a4b4181d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904215208a4b4181d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2564352552","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564352552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564352552?lang=zh_cn&edition=full","pubTime":"2025-09-02 22:08","pubTimestamp":1756822127,"startTime":"0","endTime":"0","summary":"北京时间2025年09月02日22时08分，Moleculin Biotech, Inc.股票出现异动，股价急速下跌5.02%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Carisma Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Carisma Therapeutics, Inc.、Hoth Therapeutics, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为524.12%、92.10%、38.17%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Carisma Therapeutics, Inc.、Mineralys Therapeutics, Inc.，振幅分别为66.67%、57.63%、41.86%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902220847a4afe6a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902220847a4afe6a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"1191506177","title":"Moleculin Biotech, Inc.完成1B/2期(Mb-106)临床试验，评估Annamycin联合阿糖胞苷疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1191506177","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191506177?lang=zh_cn&edition=full","pubTime":"2025-08-27 20:48","pubTimestamp":1756298930,"startTime":"0","endTime":"0","summary":"Moleculin Biotech, Inc.宣布已完成其1B/2期(Mb-106)临床试验，该试验旨在评估Annamycin与阿糖胞苷联合治疗的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2558139666","title":"Moleculin Biotech, Inc.盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558139666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558139666?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:32","pubTimestamp":1754919162,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时32分，Moleculin Biotech, Inc.股票出现异动，股价快速跳水5.11%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为1780.40%、217.08%、76.88%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为33.16%、32.31%、11.88%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112132429740e3cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112132429740e3cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2557370606","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557370606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557370606?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487175,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，Moleculin Biotech, Inc.股票出现异动，股价急速上涨5.48%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biomx Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、诺瓦瓦克斯医药涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为329.41%、277.36%、14.14%，振幅较大的相关个股有Biomx Inc.、Fractyl Health, Inc.、Sutro Biopharma, Inc.，振幅分别为13.47%、9.36%、8.06%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213255a478d8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213255a478d8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"2556824193","title":"Moleculin Biotech, Inc.盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556824193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556824193?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:30","pubTimestamp":1754314245,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时30分，Moleculin Biotech, Inc.股票出现异动，股价大幅下跌5.20%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2102.78%、741.50%、368.77%，振幅较大的相关个股有Camp4 Therapeutics Corporation、Psyence Biomedical Ltd.、Telix Pharmaceutic，振幅分别为9.08%、8.46%、8.12%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042130459732ef8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508042130459732ef8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2556847912","title":"Moleculin Biotech, Inc.8月1日成交额为140.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556847912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556847912?lang=zh_cn&edition=full","pubTime":"2025-08-02 11:50","pubTimestamp":1754106615,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Moleculin Biotech, Inc.成交额为140.01万美元，成交额较昨日减少20.39%，当日成交量为214.60万股。Moleculin Biotech, Inc.于2025年8月1日涨5.91%，报0.665美元，该股过去5个交易日涨17.3%，年初至今跌60.88%，过去60日跌34.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-01|140.01万|-20.39%|214.60万|#|2025-07-31|175.87万|-52.39%|269.49万|#|2025-07-30|369.43万|-69.92%|522.76万|#|2025-07-29|1228.28万|601.37%|1853.24万|#|2025-07-28|175.13万|15.01%|306.53万|Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115020a6ceca73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802115020a6ceca73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2555831475","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555831475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555831475?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:32","pubTimestamp":1753968730,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时32分，Moleculin Biotech, Inc.股票出现波动，股价大幅下挫5.01%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。其相关个股中，Soligenix, Inc.、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为3631.51%、1769.23%、1724.71%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Soligenix, Inc.，振幅分别为32.00%、17.78%、13.60%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213210a46db376&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213210a46db376&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moleculin.com","stockEarnings":[{"period":"1week","weight":0.0413},{"period":"1month","weight":-0.1386},{"period":"3month","weight":-0.6635},{"period":"6month","weight":-0.7946},{"period":"1year","weight":-0.896},{"period":"ytd","weight":0.2961}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司，着眼于开发抗癌药物的研发，主要与德克萨斯州大学的M.D. Anderson癌症中心合作。该公司的主要研制药品是脂质的安那霉素，用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物，一是WP1066药物，主要控制参与癌症的关键转录调控因子；二是WP1122药物，主要通过分子靶来影响癌症细胞的代谢过程。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.015822},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.078146},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.125735},{"month":4,"riseRate":0.444444,"avgChangeRate":0.079306},{"month":5,"riseRate":0.111111,"avgChangeRate":-0.074587},{"month":6,"riseRate":0.222222,"avgChangeRate":0.038146},{"month":7,"riseRate":0.6,"avgChangeRate":0.174639},{"month":8,"riseRate":0.2,"avgChangeRate":-0.127636},{"month":9,"riseRate":0.2,"avgChangeRate":-0.037317},{"month":10,"riseRate":0.1,"avgChangeRate":-0.140808},{"month":11,"riseRate":0.5,"avgChangeRate":0.009369},{"month":12,"riseRate":0.3,"avgChangeRate":-0.109934}],"exchange":"NASDAQ","name":"Moleculin Biotech, Inc.","nameEN":"Moleculin Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moleculin Biotech, Inc.,MBRX,Moleculin Biotech, Inc.股票,Moleculin Biotech, Inc.股票老虎,Moleculin Biotech, Inc.股票老虎国际,Moleculin Biotech, Inc.行情,Moleculin Biotech, Inc.股票行情,Moleculin Biotech, Inc.股价,Moleculin Biotech, Inc.股市,Moleculin Biotech, Inc.股票价格,Moleculin Biotech, Inc.股票交易,Moleculin Biotech, Inc.股票购买,Moleculin Biotech, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}